BRAF mutation has been extensively studied and associated with various tumors. Targeted therapeutic intervention against BRAF mutation is established modality against many such tumors. Various studies have estimated that the prevalence of BRAF mutation in colorectal carcinoma (CRC) is 5%-25%. Considering epidemiology differences from Western population and paucity of studies on BRAF mutation in CRC in Asian patients, the present study was done to study the BRAF mutation in CRC in Indian population.

Journal of cancer research and therapeutics

6

1969

http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2018;volume=14;issue=6;spage=1403;epage=1406;aulast=Saxena

J Cancer Res Ther